Atom Investors LP Vertex Pharmaceuticals Inc Transaction History

Atom Investors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $690,225 - $739,780	2,041 Added 283.87%	2,760 $959,000
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $4,087 - $4,574	13 Added 1.84%	719 $253,000
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $199,960 - $228,108	706 New	706 $222,000
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $517,146 - $643,902	-2,201 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $487,345 - $574,394	2,201 New	2,201 $574,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.